Exploring therapeutic mechanisms to improve organ function in CVRM diseases

Chair: Hiddo Heerspink (NLD)

15:30 – 15:35IntroductionHiddo Heerspink (NLD)
15:35 – 15:55Beneficial effects of GLP-1—weight loss mediated versus direct action?Carel le Roux (IRL)
15:55 – 16:15Mechanistic synergies of the actions of SGLT2i’s and GLP1Ra’s on heart and liverIldiko Lingvay (USA)
16:15 – 16:35Mechanistic synergies of the actions of SGLT2i’s and GLP1Ra’s on kidney protection Hiddo Heerspink (NLD)
16:35 – 16:55How can we utilize the mechanistic insights to further improve treatments of patients? All Faculty
16:55 – 17:00Summary and closeHiddo Heerspink (NLD)